Coronary heart disease, hypercholesterolemia, and atherosclerosis I. False premises

Experimental and Molecular Pathology

Volumn 70, Issue 2, 2001, Pages 103-119

  Stehbens, William E ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Atherosclerosis; Cholesterol; Coronary heart disease; Epidemiological methods; Hypercholesterolemic lipid hypothesis; Lipid dystrophies; Lipoproteins; Reference range

Indexed keywords

CHOLESTEROL; HUMORAL ANTIBODY; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGE DISTRIBUTION; ARTERY LESION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; CORRELATION ANALYSIS; DEVELOPING COUNTRY; FAMILIAL DEFECTIVE APOLIPOPROTEIN B100; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILIAL HYPERLIPEMIA; GEOGRAPHIC DISTRIBUTION; HEART INFARCTION; HEMODYNAMICS; HERBIVORY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; HYPERLIPOPROTEINEMIA TYPE 3; IATROGENIC DISEASE; INTIMA; ISCHEMIC HEART DISEASE; LIPIDOSIS; NONHUMAN; RISK FACTOR; VASCULAR LESION;

ANIMALIA;

EID: 0035568867     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1006/exmp.2000.2340     Document Type: Article

References (206)

1. Clinicopathologic conference: A fifty-year-old man with skin pigmentation, arthritis, chronic renal failure and methemoglobinemia
2. Genetics of atherosclerosis. Studies of families with xanthoma and unselected patients with coronary artery disease under the age of fifty years
3. Type III hyperlipoproteinemia with mesangial foam cells in renal glomeruli
4. Experimental arteriosclerosis in animals
5. On experimental cholesterin steatosis and its significance in the origin of some pathological processes
6. Hypothesis: Heated milk protein and thrombus
7. Atherosclerosis in rhesus and cynomolgus monkeys
8. Introduction
9. The uncertainty of determining the mode and time of death without an autopsy
10. Uncertainty of determining cause of death in a medico-legal material without autopsy. An autopsy study
11. Primary familial hyperlipoproteinemia in young adults with myocardial infarction and their relatives
12. Familial combined hyperlipidemia
13. Pathologic findings in the aortocoronary vein grafts. A scanning electron microscope study
14. Cholesterol and mortality in New Zealand Maoris
15. Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis
16. Cardiac manifestations of Fabry's disease
17. Cardiovascular risk factors in children
18. Effect of dietary cholesterol on erythrocyte peroxidant stress in vitro and in vivo
19. On the definition of "atherosclerosis" in clinical studies
20. Hypercholesterolemia, myxedema and atherosclerosis
21. Morphology
22. Cholesterol, lipoproteins, and coronary heart disease in women
23. Nonhuman primate models of atherosclerosis
24. Predictors of mortality in very old subjects aged 80 years or over
25. Experiments on animals and human populations
26. Disease burden in sub-Sarahan Africa: What should we conclude in the absence of data?
27. Familial defective apo B-100, characterization of an Italian Family
28. Coronary heart disease as an epidemiological entity
29. An approach to longitudinal studies in a community: The Framingham study
30. Epidemiological approaches to heart disease: The Framingham Study
31. II Coronary heart disease in the Framingham study
32. Patterns of atherosclerosis: Effect of risk factors on recurrence and survival - Analysis of 11,890 cases with more than 25 years follow-up
33. Experimental cholesterol arteriosclerosis and its relationship to human arteriosclerosis
34. Pathology of atherosclerosis
35. The value and limitations of necropsy studies in coronary arterial disease
36. The epidemiology of coronary heart disease
37. Coronary intimal sclerosis in Morquio's syndrome
38. The relation of antemortem characteristics to cardiovascular findings at necropsy
39. Nikolaj Nikolajewitsch Anitschkow (1885-1964) established the cholesterol-fed rabbit as a model for atherosclerosis research
40. The role of lipids in acute myocardial infarction
41. Blood cholesterol is causally related to atherosclerosis
42. Familial lipoprotein disorders in patients with premature coronary artery disease
43. Pathologic findings in homocystinuria
44. Pathologie comparée de l'athérosclérose spontańee
45. Appraisal of dietary fat as a causative factor in atherogenesis
46. Neonatal familial type II hyperlipoproteinermia: Cord blood cholesterol in 1800 births
47. Genetic aspects of arteriosclerosis
48. The value of the autopsy in three medical eras
49. Familial hypercholesterolemia
50. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction
51. Hyperlipidemia in coronary heart disease. II Genetic delineation of a new inherited disorder, combined hyperlipidemia
52. Type III hyperlipoproteinemia and atherosclerosis: A case report and reevaluation
53. X-Ray microanalysis of mineralized matrix vesicles of experimental saccular aneurysms
54. Cholesterol and coronary heart disease
55. Familial combined hyperlipidemia workshop
56. Phenotypic variation on patients heterozygous for familial defective apoliprotein B (FDB). In three European countries
57. Lipoprotein-cholesterol distribution in selected North American Populations: The Lipid Research Clinics Program Prevalence Study
58. The environment and disease: Association or causation?
59. Identification and relative weight of cardiovascular risk factors
60. Electron microscopic studies of experimentally produced fibromuscular arterial lesions
61. Coronary arteries in newborn children
62. Apparent role of cholesterol as an erythrocyte membrane anti-oxidant
63. Recent evidence supporting psychologic and social risk factors for coronary disease
64. Coronary disease in familial hypercholesterolemia
65. The ultrastructure of arteries proximal to chronic experimental carotid-jugular arteriovenous fistulae in rabbits
66. Ultrastructure of the afferent arteries of experimental femoral arteriovenous fistulae in rabbits
67. The biochemistry of blood lipid regulation and the assessemnt of lipid abnormalities
68. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Demographic, physical, dietary and biochemical characteristics
69. The role of cholesterol in coronary atherogenesis
70. Recent highlights from the Framingham Study
71. Hypertension and other risk factors in coronary heart disease
72. Incidence and prognosis of unrecognized myocardial infarction
73. Cholesterol in the prediction of atherosclerotic disease
74. Serum lipid precursors of coronary heart disease
75. The unrecognized myocardial infarction
76. Declining cardiovascular mortality
77. The age trend of serum concentrations of cholesterol and of Sf 10-20 ("G") substances in adults
78. Atherosclerosis: A problem in newer public health
79. The inheritance of essential familial hypercholesterolemia
80. A general review of clinical and laboratory features of familial hypercholesterolemia (type II hyperlipoproteinemia)
81. Experiences with the homozygous cases of familial hypercholesterolemia
82. Production of advanced coronary atherosclerosis, myocardial infarction and "sudden death" in swine
83. Accuracy of death certificates for coding coronary heart disease as the cause of death
84. Causes of death in patients with familial hypercholesterolemia
85. Homozygous familial hypercholesterolemia in Japan
86. A short history of the diet/heart hypothesis
87. Coronary heart disease: Rise and fall of a modern epidemic
88. Mechanisms of ischemic cardiac pain and silent myocardial ischemia
89. Appraisal of cholesterol as a causative factor in atherogenesis
90. The mucopolysaccharide storage diseases
91. Functional morphology of arteries during fetal and post-natal development
92. Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: A case with high plant sterol absorption, unpaired sterol elimination and low cholesterol synthesis
93. Atheroarteriosclerosis induced by infection with a herpes virus
94. Experimental induction of atheroarteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet. II. Effect of repeatedly injected foreign particles in rabbits fed a lipid-rich, cholesterol-poor diet
95. The biochemical, clinical, and genetic factors of type III hyperlipoproteinemia
96. The cause of arteriosclerosis
97. The genetic hyperlipidemias
98. Can patients with chest pain and normal coronary arteries be discriminated from those with coronary artery disease prior to coronary angiography?
99. Angina pectoris in hereditary xanthomatosis
100. Familial defective apoliproprotein B-100: A review, including some comparisons with familial hypercholesterolaemia
101. Vibration analysis in experimental models of atherosclerosis
102. Serum cholesterol - The knave of hearts and the joker
103. Strategies for preventing and screening for coronary heart disease
104. Introduction: Lipids and coronary disease - Resolved and unresolved problems
105. Is there an optimun diet for the prevention of coronary heart disease?
106. The pathogenesis of arteriosclerosis
107. Lipemia and the reticulo-endothelial apparatus
108. Pathophysiological events during pregnancy influence the development of atherosclerosis in humans
109. New approaches for epidemiologic studies of mortality statistics
110. Coronary heart disease in the absence of hypercholesterolaemia
111. The heart in Hurler syndrome. Gross, histologic and ultrastructural observations in five necropsy cases
112. Report of the Working Group on Arteriosclerosis of the National Heart, Lung, and Blood Institute
113. Necropsy observations in familial type III hyperlipoproteinemia
114. Hyperlipoproteinemia. A review of the five types with first report of necropsy findings in type 3
115. What is epidemiology?
116. Serum betalipoprotein studies in the South African Bantu
117. Ten-year observations on autologous pericardial and venous grafts in the thoracic aorta
118. Familial diseases with storage of sterols other than cholesterol: Cerebrotendinous xanthomatosis and sitosterolemia with xanthomatosis
119. Arteriosclerosis in animal experiments and in man
120. Studies of serum cholesterol in 4,244 men and women: An epidemiological and pathogenetic interpretation
121. Familial hypercholesterolemia in a large kindred. Evidence for a monogenic mechanism
122. Risk of fatal coronary heart disease in familial hypercholesterolaemia
123. Unravelling atherosclerosis
124. Hyperlipidaemia and the prevention of coronary heart disease
125. Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries
126. Lifestyles, major risk factors, proof and public policy
127. The prevention and control of epidemic coronary heart disease: Scientific foundations and strategic approaches
128. Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children
129. Natural history and histological classification of atherosclerotic lesions. An update
130. A definition of the intima of human arteries and its atherosclerosis-prone regions
131. Atherosclerosis regression in animal models: Current concepts of cellular and biochemical mechanisms
132. Cerebral aneurysm and congenital abnormalities
133. Intimal proliferation and spontaneous lipid deposition in the cerebral arteries of sheep and steers
134. Experimental arteriovenous fistulae in normal and cholesterol-fed rabbits
135. Haemodynamic production of lipid deposition, intimal tears, mural dissection and thrombosis in the blood vessel wall
136. The ultrastructure of the anastomosed vein of experimental arteriovenous fistulae in sheep
137. Cerebral atherosclerosis
138. The role of lipid in the pathogenesis of atherosclerosis
139. Hemodynamics and diseases of systemic blood vessels
140. Chronic vascular changes in the walls of experimental berry aneurysms of the aortic bifurcation in rabbits
141. The ultrastructure of experimental aneurysms in rabbits
142. An appraisal of cholesterol-feeding in experimental atherogenesis
143. Vascular complications in experimental atherosclerosis
144. Experimental arterial loops and arterial atrophy
145. An appraisal of the epidemic rise of coronary heart disease and its decline
146. The controversial role of dietary cholesterol and hyercholesterolemia in the etiology of atherosclerosis
147. Diet and atherogenesis
148. Review of the validity of national coronary heart disease mortality rates
149. Imprecision of the clinical diagnosis of coronary heart disease in epidemiological studies and atherogenesis
150. Validity of cerebrovascular mortality rates
151. Causality in medical science with reference to coronary heart disease and atherosclerosis
152. Experimental induction of atherosclerosis associated with femoral arteriovenous fistulae in rabbits on a stock diet
153. Atherosclerosis and degenerative diseases of blood vessels
154. The hypothetical epidemic of coronary heart disease and atherosclerosis
155. Histological changes in chronic experimental aneurysms surgically fashioned in sheep
156. The pathogenesis of atherosclerosis: A critical evaluation of the evidence
157. Lipids and atherosclerosis: The impossible causal relationship reaffirmed
158. Epidemiological risk factors of coronary heart disease are not causal in atherosclerosis
159. The histopathology of endocardial sclerosis
160. Venous atherosclerosis associated with arteriovenous fistulas for hemodialysis
161. The susceptibility of renal arterial forks in rabbits to dietary-induced lipid deposition
162. Light and scanning electron microscopic changes observed in experimental arterial forks in rabbits
163. Serum cholesterol correlation with atherosclerosis
164. The relationship of hypercholesterolemia to atherosclerosis with particular emphasis on familial hypercholesterolemia, diabetes mellitus, obstructive jaundice, myxedema and the nephrotic syndrome
165. Beyond cholesterol. Modifications of low-density lipo-protein that increase its atherogenicity
166. Atherosclerosis and coronary heart disease: The contribution of epidemiology
167. Risk factors and atherosclerotic lesions
168. Xanthomatoses
169. The signficance of cholesterol in the pathogenesis of vascular lesions
170. Trends in total mortality and mortality from heart disease in 26 countries from 1950 to 1978
171. Diet and plasma lipids in a reappraisal
172. Paunches and the prediction of coronary heart disease
173. Familial defective apoliprotein B-100: A single mutation that causes hypercholesterolemia and premature coronary heart disease
174. Limitations of the forensic external examination in determining the cause and manner of death
175. Animal models of atherosclerosis, their contributions and pitfalls
176. Animal models and the study of atherosclerosis
177. Familial hypercholesterolemia in the Finnish North Karelia. A molecular, clinical and genealogical study
178. Necropsy rates in the United Birmingham Hospitals
179. Sudden death in coronary thrombosis
180. Atherosclerotic and nonatherosclerotic coronary artery factors in acute myocardial infarction
181. Complex segregation analysis of hyperlipidemia in a Seattle sample
182. Clinical features of familial hypercholesterolemia
183. Fat in the diet and mortality from heart disease
184. On the methodology of investigations of etiologic factors in chronic diseases
185. Failure to diagnose acute myocardial infarction. The clinicopathologic experience at a large community hospital